Ireland is the latest country to temporarily suspend use of the Oxford-AstraZeneca vaccine due to blood clot concerns.
Irish Deputy Chief Medical Officer Dr. Ronan Glynn said the break was a precaution.
He said there was no link between the vaccine and reports of small numbers of blood clots in Norway, but they would stop giving it until more information was available.
The country is joining at least nine other countries, including Italy, Denmark, Austria and Latvia, to stop using the Covid-19 vaccine.
Dr. Glynn said: “It was not concluded that the Covid-19 vaccine AstraZeneca was linked to these cases.
“However, due to the precautionary principle and pending further information, the National Immunization Advisory Committee has recommended that the vaccination program against the Covid-19 vaccine AstraZeneca in Ireland be temporarily postponed.”
The World Health Organization is investigating but said no causal link had been made between the shot and the reported health problems, of which there are fewer than 50 cases.
The UK drug and health products regulator said people should still be getting their Covid-19 bumps.
They said there is no evidence that the vaccine causes blood clot problems.
This coincided with AstraZeneca’s statement on Friday that there was “no evidence” that the vaccine caused an increased risk of developing blood clots.
More than 11 million doses of the Oxford sting have been administered in the UK. Many millions more were administered worldwide.